Feed 6160.HK
61
BeOne Medicines AG
6160.HK · HKSE
$218.60 +2.53% (+$5.40)
1M +12.84%
Market Cap $34.3B
P/E Ratio 119.38x
Div. Yield -
ROE 7.11%
Bulios Fair Price
$266.77
22.0% upside
Aktuální cena
$218.6
Podhodnoceno Férová hodnota Nadhodnoceno
Podle Bulios Fair Price je akcie 6160.HK aktuálně podhodnocená vůči své tržní ceně. Jak to funguje?
Valuation
11 /100
Expensive P/E 119.38x
P/B 7.87x
EV/EBITDA 52.25x
Growth
83 /100
Growing Rev. growth 55.76%
Book val. growth 0.17%
EPS growth N/A
Profitability
68 /100
Strong Gross margin 85.28%
FCF margin 17.63%
Net margin 5.37%
Quality
33 /100
Poor ROIC 4.78%
Asset turnover 0.65x
ROE 7.11%
Debt
95 /100
Low Debt/Equity 0.25x
Net debt/EBITDA -5.93x
Current ratio 3.41x
Stability
49 /100
Moderate Beta 0.50x
Profitable years 1
Rev. volatility 16.65%
Zeptejte se StockBota na 6160.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John V. Oyler
Employees
12,000
Headquarters
Basel
Nadcházející události
05 LIS
Earnings
Upcoming earnings report